152 related articles for article (PubMed ID: 26111262)
1. First Human Study of the Investigational Sedative and Anesthetic Drug AZD3043: A Dose-Escalation Trial to Assess the Safety, Pharmacokinetics, and Efficacy of a 30-Minute Infusion in Healthy Male Volunteers.
Kalman S; Koch P; Ahlén K; Kanes SJ; Barassin S; Björnsson MA; Norberg Å
Anesth Analg; 2015 Oct; 121(4):885-893. PubMed ID: 26111262
[TBL] [Abstract][Full Text] [Related]
2. A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers.
Norberg Å; Koch P; Kanes SJ; Björnsson MA; Barassin S; Ahlén K; Kalman S
Anesth Analg; 2015 Oct; 121(4):894-903. PubMed ID: 26097986
[TBL] [Abstract][Full Text] [Related]
3. A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers.
Björnsson MA; Norberg Å; Kalman S; Simonsson USH
Anesth Analg; 2015 Oct; 121(4):904-913. PubMed ID: 26097984
[TBL] [Abstract][Full Text] [Related]
4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
[TBL] [Abstract][Full Text] [Related]
5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
6. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
[TBL] [Abstract][Full Text] [Related]
7. Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED; Keating GM; Keam SJ
Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
[TBL] [Abstract][Full Text] [Related]
8. A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.
Cuvier V; Lorch U; Witte S; Olivier A; Gibot S; Delor I; Garaud JJ; Derive M; Salcedo-Magguilli M
Br J Clin Pharmacol; 2018 Oct; 84(10):2270-2279. PubMed ID: 29885068
[TBL] [Abstract][Full Text] [Related]
9. A Phase 1c Trial Comparing the Efficacy and Safety of a New Aqueous Formulation of Alphaxalone with Propofol.
Monagle J; Siu L; Worrell J; Goodchild CS; Serrao JM
Anesth Analg; 2015 Oct; 121(4):914-924. PubMed ID: 26226029
[TBL] [Abstract][Full Text] [Related]
10. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.
Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM
Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765
[TBL] [Abstract][Full Text] [Related]
11. Reduced efficacy of the intravenous anesthetic agent AZD3043 at GABA(A) receptors with β2 (N289M) and β3 (N290M) point-mutations.
Jonsson Fagerlund M; Sjödin J; Dabrowski MA; Krupp J
Eur J Pharmacol; 2012 Nov; 694(1-3):13-9. PubMed ID: 23009769
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
[TBL] [Abstract][Full Text] [Related]
13. A phase I, dose-escalation trial evaluating the safety and efficacy of emulsified isoflurane in healthy human volunteers.
Huang H; Li R; Liu J; Zhang W; Liao T; Yi X
Anesthesiology; 2014 Mar; 120(3):614-25. PubMed ID: 24162462
[TBL] [Abstract][Full Text] [Related]
14. HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
Ottoboni T; Lauw M; Keller MR; Cravets M; Manhard K; Clendeninn N; Quart B
Future Oncol; 2019 Mar; 15(8):865-874. PubMed ID: 30574797
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.
Iirola T; Aantaa R; Laitio R; Kentala E; Lahtinen M; Wighton A; Garratt C; Ahtola-Sätilä T; Olkkola KT
Crit Care; 2011; 15(5):R257. PubMed ID: 22030215
[TBL] [Abstract][Full Text] [Related]
16. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
Egan TD; Obara S; Jenkins TE; Jaw-Tsai SS; Amagasu S; Cook DR; Steffensen SC; Beattie DT
Anesthesiology; 2012 Jun; 116(6):1267-77. PubMed ID: 22531340
[TBL] [Abstract][Full Text] [Related]
17. Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial.
Hu C; Ou X; Teng Y; Shu S; Wang Y; Zhu X; Kang Y; Miao J
Adv Ther; 2021 Nov; 38(11):5484-5500. PubMed ID: 34559359
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
Geisser P; Banké-Bochita J
Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
[TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
Candiotti KA; Gan TJ; Young C; Bekker A; Sum-Ping ST; Kahn R; Lebowitz P; Littman JJ
Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative/hypnotic agents.
Zhang H; Xu X; Chen Y; Qiu Y; Liu X; Liu BF; Zhang G
PLoS One; 2014; 9(5):e96518. PubMed ID: 24796695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
